Friday 26th August, 2016   |   Welcome, guest. Please, login or register  
Friday December 10, 21:07

Thelin: Withdrawal from sale

Pulmonary arterial hypertension is an incurable disease that can cause shortness of breath, and even go so far as stopping the heart if not treated
Pulmonary arterial hypertension is an incurable disease that can cause shortness of breath, and even go so far as stopping the heart if not treated
 

The pharmaceutical company Pfizer announced Friday about the withdrawal of its medicinal product Thelin, against a relatively rare disease, pulmonary arterial hypertension in markets where it is allowed, Europe, Australia and Canada.

Pfizer said it had taken this decision because of a new risk of liver lesion "potentially lethal",  in patients with pulmonary arterial hypertension.

The European Medicines Agency, which had approved the medicine in 2006, has indicated that the toxicity of it for the liver had always been known.

At this stage, patients taking Thelin or participating in the studies of Thelin are encouraged not to interrupt their treatment but ask for physicians treatment.

Pfizer suspends the current tests, and calls for Thelin to no longer be prescribed and that patients get other treatments.

Pulmonary arterial hypertension is an incurable disease that can cause shortness of breath, and even go so far as stopping the heart if not treated. According to the spokesman, 12,500 patients suffering this disease in the U.S..

Pfizer says that the disease affects between 100,000 and 200,000 people throughout North America and Europe. The low specificity of symptomes often lead to late diagnosys.

 
 
Rate:
 
 

Recommended articles:

 

Statins against cholesterol: Still debated

Vasten (a statin) is prescribed to fight cholesterol
These cholesterol drugs reduce the risk of cardiovascular events. But the question about their being so useful remains debated.
 

Should we all take cholesterol-lowering drugs?

Statins may be prescribed to individuals without cardiovascular disease or apparent high LDL cholesterol, but considered at risk for cardiovascular disease
In the U.S., these cholesterol drugs are now allowed for a growing number of people without high cholesterol. To a significant cost.
 

Statins, the new panacea?

Statins could reduce the risk of various malignancies, including those of prostate and breast
The epidemiological and biochemical data have recently suggested that statins could reduce the risk of various malignancies, including those of prostate and breast.
 

Most recent in the category Social Health:

 
 
 

Last comments

 

No comments. Be the first to comment the article!

 
Please, login or post your comment anonymously.

Your comment:

 
 
 
 
 

Home | Social Health | AIDS | Cancer | Diseases | Diet | Human body | Most read | Top rated

RSS | Feedback | Headlines for your website | Terms of Service/Privacy policy

Copyright © 2016 Heal-all.org. All rights reserved.